The global Male Hypogonadism market is projected to grow from US$ 3209.2 million in 2023 to US$ 3721.7 million by 2029, at a Compound Annual Growth Rate (CAGR) of 2.5% during the forecast period.

Male Hypogonadism Market

Male hypogonadism is a condition in which the body doesn't produce enough of the hormone that plays a key role in masculine growth and development during puberty (testosterone) or enough sperm or both. You can be born with male hypogonadism, or it can develop later in life, often from injury or infection.

Market Analysis and Insights: Global Male Hypogonadism Market

The US & Canada market for Male Hypogonadism is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The China market for Male Hypogonadism is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The Europe market for Male Hypogonadism is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global key companies of Male Hypogonadism include Astrazeneca Plc., Merck & Co. Inc., Laboratories Genevrier, Allergan Plc., Endo International Plc., Ferring, AbbVie Inc., Eli Lilly and Company Ltd. and Finox Biotech, etc. in 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes

This report presents an overview of global market for Male Hypogonadism market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Male Hypogonadism, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Male Hypogonadism, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Male Hypogonadism revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Male Hypogonadism market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Male Hypogonadism revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Astrazeneca Plc., Merck & Co. Inc., Laboratories Genevrier, Allergan Plc., Endo International Plc., Ferring, AbbVie Inc., Eli Lilly and Company Ltd. and Finox Biotech, etc.

Scope of Male Hypogonadism Market Report

Report Metric	Details
Report Name	Male Hypogonadism Market
Accounted market size in 2023	US$ 3209.2 in million
Forecasted market size in 2029	US$ 3721.7 million
CAGR	2.5
Base Year	2023
Forecasted years	2023 - 2029
Segment by Type	Testosterone Replacement Therapy Gonadotropin-Releasing Hormones Therapy
Segment by Application	Kallmann Syndrome Klinefelters Syndrome Pituitary Disorders Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Astrazeneca Plc., Merck & Co. Inc., Laboratories Genevrier, Allergan Plc., Endo International Plc., Ferring, AbbVie Inc., Eli Lilly and Company Ltd., Finox Biotech, Teva Pharmaceutical Industries Ltd., Bayer AG, IBSA Institut Biochimque
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Male Hypogonadism in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Male Hypogonadism companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Male Hypogonadism revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Male Hypogonadism Market growing?

Ans: The Male Hypogonadism Market witnessing a CAGR of 2.5 during the forecast period 2023-2029.

What is the Male Hypogonadism Market size in 2029?

Ans: The global Male Hypogonadism market is projected to grow from US$ 3209.2 million in 2023 to US$ 3721.7 million by 2029, at a Compound Annual Growth Rate (CAGR) of 2.5% during the forecast period.

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Male Hypogonadism Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Testosterone Replacement Therapy

1.2.3 Gonadotropin-Releasing Hormones Therapy

1.3 Market by Application

1.3.1 Global Male Hypogonadism Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Kallmann Syndrome

1.3.3 Klinefelters Syndrome

1.3.4 Pituitary Disorders

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Male Hypogonadism Market Perspective (2018-2029)

2.2 Global Male Hypogonadism Growth Trends by Region

2.2.1 Male Hypogonadism Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Male Hypogonadism Historic Market Size by Region (2018-2023)

2.2.3 Male Hypogonadism Forecasted Market Size by Region (2024-2029)

2.3 Male Hypogonadism Market Dynamics

2.3.1 Male Hypogonadism Industry Trends

2.3.2 Male Hypogonadism Market Drivers

2.3.3 Male Hypogonadism Market Challenges

2.3.4 Male Hypogonadism Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Male Hypogonadism by Players

3.1.1 Global Male Hypogonadism Revenue by Players (2018-2023)

3.1.2 Global Male Hypogonadism Revenue Market Share by Players (2018-2023)

3.2 Global Male Hypogonadism Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Male Hypogonadism, Ranking by Revenue, 2021 VS 2022 VS 2023

3.4 Global Male Hypogonadism Market Concentration Ratio

3.4.1 Global Male Hypogonadism Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Male Hypogonadism Revenue in 2022

3.5 Global Key Players of Male Hypogonadism Head office and Area Served

3.6 Global Key Players of Male Hypogonadism, Product and Application

3.7 Global Key Players of Male Hypogonadism, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Male Hypogonadism Breakdown Data by Type

4.1 Global Male Hypogonadism Historic Market Size by Type (2018-2023)

4.2 Global Male Hypogonadism Forecasted Market Size by Type (2024-2029)

5 Male Hypogonadism Breakdown Data by Application

5.1 Global Male Hypogonadism Historic Market Size by Application (2018-2023)

5.2 Global Male Hypogonadism Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Male Hypogonadism Market Size (2018-2029)

6.2 North America Male Hypogonadism Market Size by Type

6.2.1 North America Male Hypogonadism Market Size by Type (2018-2023)

6.2.2 North America Male Hypogonadism Market Size by Type (2024-2029)

6.2.3 North America Male Hypogonadism Market Share by Type (2018-2029)

6.3 North America Male Hypogonadism Market Size by Application

6.3.1 North America Male Hypogonadism Market Size by Application (2018-2023)

6.3.2 North America Male Hypogonadism Market Size by Application (2024-2029)

6.3.3 North America Male Hypogonadism Market Share by Application (2018-2029)

6.4 North America Male Hypogonadism Market Size by Country

6.4.1 North America Male Hypogonadism Market Size by Country: 2018 VS 2022 VS 2029

6.4.2 North America Male Hypogonadism Market Size by Country (2018-2023)

6.4.3 North America Male Hypogonadism Market Size by Country (2024-2029)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Male Hypogonadism Market Size (2018-2029)

7.2 Europe Male Hypogonadism Market Size by Type

7.2.1 Europe Male Hypogonadism Market Size by Type (2018-2023)

7.2.2 Europe Male Hypogonadism Market Size by Type (2024-2029)

7.2.3 Europe Male Hypogonadism Market Share by Type (2018-2029)

7.3 Europe Male Hypogonadism Market Size by Application

7.3.1 Europe Male Hypogonadism Market Size by Application (2018-2023)

7.3.2 Europe Male Hypogonadism Market Size by Application (2024-2029)

7.3.3 Europe Male Hypogonadism Market Share by Application (2018-2029)

7.4 Europe Male Hypogonadism Market Size by Country

7.4.1 Europe Male Hypogonadism Market Size by Country: 2018 VS 2022 VS 2029

7.4.2 Europe Male Hypogonadism Market Size by Country (2018-2023)

7.4.3 Europe Male Hypogonadism Market Size by Country (2024-2029)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Male Hypogonadism Market Size (2018-2029)

8.2 China Male Hypogonadism Market Size by Type

8.2.1 China Male Hypogonadism Market Size by Type (2018-2023)

8.2.2 China Male Hypogonadism Market Size by Type (2024-2029)

8.2.3 China Male Hypogonadism Market Share by Type (2018-2029)

8.3 China Male Hypogonadism Market Size by Application

8.3.1 China Male Hypogonadism Market Size by Application (2018-2023)

8.3.2 China Male Hypogonadism Market Size by Application (2024-2029)

8.3.3 China Male Hypogonadism Market Share by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia Male Hypogonadism Market Size (2018-2029)

9.2 Asia Male Hypogonadism Market Size by Type

9.2.1 Asia Male Hypogonadism Market Size by Type (2018-2023)

9.2.2 Asia Male Hypogonadism Market Size by Type (2024-2029)

9.2.3 Asia Male Hypogonadism Market Share by Type (2018-2029)

9.3 Asia Male Hypogonadism Market Size by Application

9.3.1 Asia Male Hypogonadism Market Size by Application (2018-2023)

9.3.2 Asia Male Hypogonadism Market Size by Application (2024-2029)

9.3.3 Asia Male Hypogonadism Market Share by Application (2018-2029)

9.4 Asia Male Hypogonadism Market Size by Region

9.4.1 Asia Male Hypogonadism Market Size by Region: 2018 VS 2022 VS 2029

9.4.2 Asia Male Hypogonadism Market Size by Region (2018-2023)

9.4.3 Asia Male Hypogonadism Market Size by Region (2024-2029)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Male Hypogonadism Market Size (2018-2029)

10.2 Middle East, Africa, and Latin America Male Hypogonadism Market Size by Type

10.2.1 Middle East, Africa, and Latin America Male Hypogonadism Market Size by Type (2018-2023)

10.2.2 Middle East, Africa, and Latin America Male Hypogonadism Market Size by Type (2024-2029)

10.2.3 Middle East, Africa, and Latin America Male Hypogonadism Market Share by Type (2018-2029)

10.3 Middle East, Africa, and Latin America Male Hypogonadism Market Size by Application

10.3.1 Middle East, Africa, and Latin America Male Hypogonadism Market Size by Application (2018-2023)

10.3.2 Middle East, Africa, and Latin America Male Hypogonadism Market Size by Application (2024-2029)

10.3.3 Middle East, Africa, and Latin America Male Hypogonadism Market Share by Application (2018-2029)

10.4 Middle East, Africa, and Latin America Male Hypogonadism Market Size by Country

10.4.1 Middle East, Africa, and Latin America Male Hypogonadism Market Size by Country: 2018 VS 2022 VS 2029

10.4.2 Middle East, Africa, and Latin America Male Hypogonadism Market Size by Country (2018-2023)

10.4.3 Middle East, Africa, and Latin America Male Hypogonadism Market Size by Country (2024-2029)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Astrazeneca Plc.

11.1.1 Astrazeneca Plc. Company Details

11.1.2 Astrazeneca Plc. Business Overview

11.1.3 Astrazeneca Plc. Male Hypogonadism Introduction

11.1.4 Astrazeneca Plc. Revenue in Male Hypogonadism Business (2018-2023)

11.1.5 Astrazeneca Plc. Recent Developments

11.2 Merck & Co. Inc.

11.2.1 Merck & Co. Inc. Company Details

11.2.2 Merck & Co. Inc. Business Overview

11.2.3 Merck & Co. Inc. Male Hypogonadism Introduction

11.2.4 Merck & Co. Inc. Revenue in Male Hypogonadism Business (2018-2023)

11.2.5 Merck & Co. Inc. Recent Developments

11.3 Laboratories Genevrier

11.3.1 Laboratories Genevrier Company Details

11.3.2 Laboratories Genevrier Business Overview

11.3.3 Laboratories Genevrier Male Hypogonadism Introduction

11.3.4 Laboratories Genevrier Revenue in Male Hypogonadism Business (2018-2023)

11.3.5 Laboratories Genevrier Recent Developments

11.4 Allergan Plc.

11.4.1 Allergan Plc. Company Details

11.4.2 Allergan Plc. Business Overview

11.4.3 Allergan Plc. Male Hypogonadism Introduction

11.4.4 Allergan Plc. Revenue in Male Hypogonadism Business (2018-2023)

11.4.5 Allergan Plc. Recent Developments

11.5 Endo International Plc.

11.5.1 Endo International Plc. Company Details

11.5.2 Endo International Plc. Business Overview

11.5.3 Endo International Plc. Male Hypogonadism Introduction

11.5.4 Endo International Plc. Revenue in Male Hypogonadism Business (2018-2023)

11.5.5 Endo International Plc. Recent Developments

11.6 Ferring

11.6.1 Ferring Company Details

11.6.2 Ferring Business Overview

11.6.3 Ferring Male Hypogonadism Introduction

11.6.4 Ferring Revenue in Male Hypogonadism Business (2018-2023)

11.6.5 Ferring Recent Developments

11.7 AbbVie Inc.

11.7.1 AbbVie Inc. Company Details

11.7.2 AbbVie Inc. Business Overview

11.7.3 AbbVie Inc. Male Hypogonadism Introduction

11.7.4 AbbVie Inc. Revenue in Male Hypogonadism Business (2018-2023)

11.7.5 AbbVie Inc. Recent Developments

11.8 Eli Lilly and Company Ltd.

11.8.1 Eli Lilly and Company Ltd. Company Details

11.8.2 Eli Lilly and Company Ltd. Business Overview

11.8.3 Eli Lilly and Company Ltd. Male Hypogonadism Introduction

11.8.4 Eli Lilly and Company Ltd. Revenue in Male Hypogonadism Business (2018-2023)

11.8.5 Eli Lilly and Company Ltd. Recent Developments

11.9 Finox Biotech

11.9.1 Finox Biotech Company Details

11.9.2 Finox Biotech Business Overview

11.9.3 Finox Biotech Male Hypogonadism Introduction

11.9.4 Finox Biotech Revenue in Male Hypogonadism Business (2018-2023)

11.9.5 Finox Biotech Recent Developments

11.10 Teva Pharmaceutical Industries Ltd.

11.10.1 Teva Pharmaceutical Industries Ltd. Company Details

11.10.2 Teva Pharmaceutical Industries Ltd. Business Overview

11.10.3 Teva Pharmaceutical Industries Ltd. Male Hypogonadism Introduction

11.10.4 Teva Pharmaceutical Industries Ltd. Revenue in Male Hypogonadism Business (2018-2023)

11.10.5 Teva Pharmaceutical Industries Ltd. Recent Developments

11.11 Bayer AG

11.11.1 Bayer AG Company Details

11.11.2 Bayer AG Business Overview

11.11.3 Bayer AG Male Hypogonadism Introduction

11.11.4 Bayer AG Revenue in Male Hypogonadism Business (2018-2023)

11.11.5 Bayer AG Recent Developments

11.12 IBSA Institut Biochimque

11.12.1 IBSA Institut Biochimque Company Details

11.12.2 IBSA Institut Biochimque Business Overview

11.12.3 IBSA Institut Biochimque Male Hypogonadism Introduction

11.12.4 IBSA Institut Biochimque Revenue in Male Hypogonadism Business (2018-2023)

11.12.5 IBSA Institut Biochimque Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Astrazeneca plc

Merck& Co. Inc

Laboratories Genevrier

Allergan plc

Endo International Plc.

Ferring

AbbVie

Eli Lilly and Company Ltd

Finox Biotech

Teva Pharmaceutical Industries Ltd

Bayer

IBSA

IBSA Institut Biochimque

List of Tables

Table 1. Global Male Hypogonadism Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029

Table 2. Key Players of Testosterone Replacement Therapy

Table 3. Key Players of Gonadotropin-Releasing Hormones Therapy

Table 4. Global Male Hypogonadism Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029

Table 5. Global Male Hypogonadism Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 6. Global Male Hypogonadism Market Size by Region (2018-2023) & (US$ Million)

Table 7. Global Male Hypogonadism Market Share by Region (2018-2023)

Table 8. Global Male Hypogonadism Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 9. Global Male Hypogonadism Market Share by Region (2024-2029)

Table 10. Male Hypogonadism Market Trends

Table 11. Male Hypogonadism Market Drivers

Table 12. Male Hypogonadism Market Challenges

Table 13. Male Hypogonadism Market Restraints

Table 14. Global Male Hypogonadism Revenue by Players (2018-2023) & (US$ Million)

Table 15. Global Male Hypogonadism Revenue Share by Players (2018-2023)

Table 16. Global Top Male Hypogonadism by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Male Hypogonadism as of 2022)

Table 17. Global Male Hypogonadism Industry Ranking 2021 VS 2022 VS 2023

Table 18. Global 5 Largest Players Market Share by Male Hypogonadism Revenue (CR5 and HHI) & (2018-2023)

Table 19. Global Key Players of Male Hypogonadism, Headquarters and Area Served

Table 20. Global Key Players of Male Hypogonadism, Product and Application

Table 21. Global Key Players of Male Hypogonadism, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Male Hypogonadism Market Size by Type (2018-2023) & (US$ Million)

Table 24. Global Male Hypogonadism Revenue Market Share by Type (2018-2023)

Table 25. Global Male Hypogonadism Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 26. Global Male Hypogonadism Revenue Market Share by Type (2024-2029)

Table 27. Global Male Hypogonadism Market Size by Application (2018-2023) & (US$ Million)

Table 28. Global Male Hypogonadism Revenue Share by Application (2018-2023)

Table 29. Global Male Hypogonadism Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 30. Global Male Hypogonadism Revenue Share by Application (2024-2029)

Table 31. North America Male Hypogonadism Market Size by Type (2018-2023) & (US$ Million)

Table 32. North America Male Hypogonadism Market Size by Type (2024-2029) & (US$ Million)

Table 33. North America Male Hypogonadism Market Size by Application (2018-2023) & (US$ Million)

Table 34. North America Male Hypogonadism Market Size by Application (2024-2029) & (US$ Million)

Table 35. North America Male Hypogonadism Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 36. North America Male Hypogonadism Market Size by Country (2018-2023) & (US$ Million)

Table 37. North America Male Hypogonadism Market Size by Country (2024-2029) & (US$ Million)

Table 38. Europe Male Hypogonadism Market Size by Type (2018-2023) & (US$ Million)

Table 39. Europe Male Hypogonadism Market Size by Type (2024-2029) & (US$ Million)

Table 40. Europe Male Hypogonadism Market Size by Application (2018-2023) & (US$ Million)

Table 41. Europe Male Hypogonadism Market Size by Application (2024-2029) & (US$ Million)

Table 42. Europe Male Hypogonadism Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 43. Europe Male Hypogonadism Market Size by Country (2018-2023) & (US$ Million)

Table 44. Europe Male Hypogonadism Market Size by Country (2024-2029) & (US$ Million)

Table 45. China Male Hypogonadism Market Size by Type (2018-2023) & (US$ Million)

Table 46. China Male Hypogonadism Market Size by Type (2024-2029) & (US$ Million)

Table 47. China Male Hypogonadism Market Size by Application (2018-2023) & (US$ Million)

Table 48. China Male Hypogonadism Market Size by Application (2024-2029) & (US$ Million)

Table 49. Asia Male Hypogonadism Market Size by Type (2018-2023) & (US$ Million)

Table 50. Asia Male Hypogonadism Market Size by Type (2024-2029) & (US$ Million)

Table 51. Asia Male Hypogonadism Market Size by Application (2018-2023) & (US$ Million)

Table 52. Asia Male Hypogonadism Market Size by Application (2024-2029) & (US$ Million)

Table 53. Asia Male Hypogonadism Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 54. Asia Male Hypogonadism Market Size by Region (2018-2023) & (US$ Million)

Table 55. Asia Male Hypogonadism Market Size by Region (2024-2029) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Male Hypogonadism Market Size by Type (2018-2023) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Male Hypogonadism Market Size by Type (2024-2029) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Male Hypogonadism Market Size by Application (2018-2023) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Male Hypogonadism Market Size by Application (2024-2029) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Male Hypogonadism Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 61. Middle East, Africa, and Latin America Male Hypogonadism Market Size by Country (2018-2023) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Male Hypogonadism Market Size by Country (2024-2029) & (US$ Million)

Table 63. Astrazeneca Plc. Company Details

Table 64. Astrazeneca Plc. Business Overview

Table 65. Astrazeneca Plc. Male Hypogonadism Product

Table 66. Astrazeneca Plc. Revenue in Male Hypogonadism Business (2018-2023) & (US$ Million)

Table 67. Astrazeneca Plc. Recent Developments

Table 68. Merck & Co. Inc. Company Details

Table 69. Merck & Co. Inc. Business Overview

Table 70. Merck & Co. Inc. Male Hypogonadism Product

Table 71. Merck & Co. Inc. Revenue in Male Hypogonadism Business (2018-2023) & (US$ Million)

Table 72. Merck & Co. Inc. Recent Developments

Table 73. Laboratories Genevrier Company Details

Table 74. Laboratories Genevrier Business Overview

Table 75. Laboratories Genevrier Male Hypogonadism Product

Table 76. Laboratories Genevrier Revenue in Male Hypogonadism Business (2018-2023) & (US$ Million)

Table 77. Laboratories Genevrier Recent Developments

Table 78. Allergan Plc. Company Details

Table 79. Allergan Plc. Business Overview

Table 80. Allergan Plc. Male Hypogonadism Product

Table 81. Allergan Plc. Revenue in Male Hypogonadism Business (2018-2023) & (US$ Million)

Table 82. Allergan Plc. Recent Developments

Table 83. Endo International Plc. Company Details

Table 84. Endo International Plc. Business Overview

Table 85. Endo International Plc. Male Hypogonadism Product

Table 86. Endo International Plc. Revenue in Male Hypogonadism Business (2018-2023) & (US$ Million)

Table 87. Endo International Plc. Recent Developments

Table 88. Ferring Company Details

Table 89. Ferring Business Overview

Table 90. Ferring Male Hypogonadism Product

Table 91. Ferring Revenue in Male Hypogonadism Business (2018-2023) & (US$ Million)

Table 92. Ferring Recent Developments

Table 93. AbbVie Inc. Company Details

Table 94. AbbVie Inc. Business Overview

Table 95. AbbVie Inc. Male Hypogonadism Product

Table 96. AbbVie Inc. Revenue in Male Hypogonadism Business (2018-2023) & (US$ Million)

Table 97. AbbVie Inc. Recent Developments

Table 98. Eli Lilly and Company Ltd. Company Details

Table 99. Eli Lilly and Company Ltd. Business Overview

Table 100. Eli Lilly and Company Ltd. Male Hypogonadism Product

Table 101. Eli Lilly and Company Ltd. Revenue in Male Hypogonadism Business (2018-2023) & (US$ Million)

Table 102. Eli Lilly and Company Ltd. Recent Developments

Table 103. Finox Biotech Company Details

Table 104. Finox Biotech Business Overview

Table 105. Finox Biotech Male Hypogonadism Product

Table 106. Finox Biotech Revenue in Male Hypogonadism Business (2018-2023) & (US$ Million)

Table 107. Finox Biotech Recent Developments

Table 108. Teva Pharmaceutical Industries Ltd. Company Details

Table 109. Teva Pharmaceutical Industries Ltd. Business Overview

Table 110. Teva Pharmaceutical Industries Ltd. Male Hypogonadism Product

Table 111. Teva Pharmaceutical Industries Ltd. Revenue in Male Hypogonadism Business (2018-2023) & (US$ Million)

Table 112. Teva Pharmaceutical Industries Ltd. Recent Developments

Table 113. Bayer AG Company Details

Table 114. Bayer AG Business Overview

Table 115. Bayer AG Male Hypogonadism Product

Table 116. Bayer AG Revenue in Male Hypogonadism Business (2018-2023) & (US$ Million)

Table 117. Bayer AG Recent Developments

Table 118. IBSA Institut Biochimque Company Details

Table 119. IBSA Institut Biochimque Business Overview

Table 120. IBSA Institut Biochimque Male Hypogonadism Product

Table 121. IBSA Institut Biochimque Revenue in Male Hypogonadism Business (2018-2023) & (US$ Million)

Table 122. IBSA Institut Biochimque Recent Developments

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Male Hypogonadism Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 2. Global Male Hypogonadism Market Share by Type: 2022 VS 2029

Figure 3. Testosterone Replacement Therapy Features

Figure 4. Gonadotropin-Releasing Hormones Therapy Features

Figure 5. Global Male Hypogonadism Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 6. Global Male Hypogonadism Market Share by Application: 2022 VS 2029

Figure 7. Kallmann Syndrome Case Studies

Figure 8. Klinefelters Syndrome Case Studies

Figure 9. Pituitary Disorders Case Studies

Figure 10. Others Case Studies

Figure 11. Male Hypogonadism Report Years Considered

Figure 12. Global Male Hypogonadism Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 13. Global Male Hypogonadism Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 14. Global Male Hypogonadism Market Share by Region: 2022 VS 2029

Figure 15. Global Male Hypogonadism Market Share by Players in 2022

Figure 16. Global Top Male Hypogonadism Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Male Hypogonadism as of 2022)

Figure 17. The Top 10 and 5 Players Market Share by Male Hypogonadism Revenue in 2022

Figure 18. North America Male Hypogonadism Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 19. North America Male Hypogonadism Market Share by Type (2018-2029)

Figure 20. North America Male Hypogonadism Market Share by Application (2018-2029)

Figure 21. North America Male Hypogonadism Market Share by Country (2018-2029)

Figure 22. United States Male Hypogonadism Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 23. Canada Male Hypogonadism Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 24. Europe Male Hypogonadism Market Size YoY (2018-2029) & (US$ Million)

Figure 25. Europe Male Hypogonadism Market Share by Type (2018-2029)

Figure 26. Europe Male Hypogonadism Market Share by Application (2018-2029)

Figure 27. Europe Male Hypogonadism Market Share by Country (2018-2029)

Figure 28. Germany Male Hypogonadism Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 29. France Male Hypogonadism Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. U.K. Male Hypogonadism Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 31. Italy Male Hypogonadism Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. Russia Male Hypogonadism Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. Nordic Countries Male Hypogonadism Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 34. China Male Hypogonadism Market Size YoY (2018-2029) & (US$ Million)

Figure 35. China Male Hypogonadism Market Share by Type (2018-2029)

Figure 36. China Male Hypogonadism Market Share by Application (2018-2029)

Figure 37. Asia Male Hypogonadism Market Size YoY (2018-2029) & (US$ Million)

Figure 38. Asia Male Hypogonadism Market Share by Type (2018-2029)

Figure 39. Asia Male Hypogonadism Market Share by Application (2018-2029)

Figure 40. Asia Male Hypogonadism Market Share by Region (2018-2029)

Figure 41. Japan Male Hypogonadism Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 42. South Korea Male Hypogonadism Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 43. China Taiwan Male Hypogonadism Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. Southeast Asia Male Hypogonadism Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 45. India Male Hypogonadism Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 46. Australia Male Hypogonadism Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Male Hypogonadism Market Size YoY (2018-2029) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Male Hypogonadism Market Share by Type (2018-2029)

Figure 49. Middle East, Africa, and Latin America Male Hypogonadism Market Share by Application (2018-2029)

Figure 50. Middle East, Africa, and Latin America Male Hypogonadism Market Share by Country (2018-2029)

Figure 51. Brazil Male Hypogonadism Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 52. Mexico Male Hypogonadism Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 53. Turkey Male Hypogonadism Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 54. Saudi Arabia Male Hypogonadism Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 55. Israel Male Hypogonadism Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 56. GCC Countries Male Hypogonadism Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 57. Astrazeneca Plc. Revenue Growth Rate in Male Hypogonadism Business (2018-2023)

Figure 58. Merck & Co. Inc. Revenue Growth Rate in Male Hypogonadism Business (2018-2023)

Figure 59. Laboratories Genevrier Revenue Growth Rate in Male Hypogonadism Business (2018-2023)

Figure 60. Allergan Plc. Revenue Growth Rate in Male Hypogonadism Business (2018-2023)

Figure 61. Endo International Plc. Revenue Growth Rate in Male Hypogonadism Business (2018-2023)

Figure 62. Ferring Revenue Growth Rate in Male Hypogonadism Business (2018-2023)

Figure 63. AbbVie Inc. Revenue Growth Rate in Male Hypogonadism Business (2018-2023)

Figure 64. Eli Lilly and Company Ltd. Revenue Growth Rate in Male Hypogonadism Business (2018-2023)

Figure 65. Finox Biotech Revenue Growth Rate in Male Hypogonadism Business (2018-2023)

Figure 66. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Male Hypogonadism Business (2018-2023)

Figure 67. Bayer AG Revenue Growth Rate in Male Hypogonadism Business (2018-2023)

Figure 68. IBSA Institut Biochimque Revenue Growth Rate in Male Hypogonadism Business (2018-2023)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions